@Alienistaem 20/05/2018 20:05Analysts, on average, have forecast annual Aimovig sales of nearly $1 billion by 2022, according to Thomson Reuters I/B/E/S. U.S. FDA approves Amgen drug for prevention of migraines | Reuters#1 de 1